{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T08:03:17Z","timestamp":1780560197937,"version":"3.54.1"},"reference-count":66,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,7,23]],"date-time":"2025-07-23T00:00:00Z","timestamp":1753228800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100010661","name":"Horizon 2020 Framework Programme","doi-asserted-by":"publisher","award":["899871"],"award-info":[{"award-number":["899871"]}],"id":[{"id":"10.13039\/100010661","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000836","name":"University of Liverpool","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000836","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000272","name":"National Institute for Health and Care Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004543","name":"China Scholarship Council","doi-asserted-by":"publisher","award":["202406820109"],"award-info":[{"award-number":["202406820109"]}],"id":[{"id":"10.13039\/501100004543","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","heartrhythmjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Heart Rhythm"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/j.hrthm.2025.07.034","type":"journal-article","created":{"date-parts":[[2025,7,24]],"date-time":"2025-07-24T23:25:16Z","timestamp":1753399516000},"page":"376-387","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Clinical phenotype of anticoagulant discontinuation and the long-term prognosis in atrial fibrillation patients with high bleeding risk: A report from the GLORIA-AF registry"],"prefix":"10.1016","volume":"23","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0383-8725","authenticated-orcid":false,"given":"Hongyu","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tommaso","family":"Bucci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven Ho Man","family":"Lam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manlin","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giulio Francesco","family":"Romiti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian","family":"Olshansky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tze Fan","family":"Chao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Menno V.","family":"Huisman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kui","family":"Hong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7566-1626","authenticated-orcid":false,"given":"Gregory Y.H.","family":"Lip","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.hrthm.2025.07.034_bib1","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1055\/s-0042-1750385","article-title":"Assessment and mitigation of bleeding risk in atrial fibrillation and venous thromboembolism: executive summary of a European and Asia-pacific expert consensus paper","volume":"122","author":"Gorog","year":"2022","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.hrthm.2025.07.034_bib2","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2022.101761","article-title":"Impact of frailty models on the prescription of oral anticoagulants and on the incidence of stroke, bleeding, and mortality in older patients with atrial fibrillation: a systematic review","volume":"82","author":"Presta","year":"2022","journal-title":"Ageing Res Rev"},{"key":"10.1016\/j.hrthm.2025.07.034_bib3","doi-asserted-by":"crossref","first-page":"2427","DOI":"10.1016\/j.mayocp.2019.06.012","article-title":"Long-term relationship between atrial fibrillation, multimorbidity and oral anticoagulant drug use","volume":"94","author":"Proietti","year":"2019","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.hrthm.2025.07.034_bib4","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1378\/chest.10-0134","article-title":"A novel user-friendly score (HAS-BLED) to assess 1-year risk of major bleeding in patients with atrial fibrillation: the Euro Heart Survey","volume":"138","author":"Pisters","year":"2010","journal-title":"Chest"},{"key":"10.1016\/j.hrthm.2025.07.034_bib5","doi-asserted-by":"crossref","first-page":"3314","DOI":"10.1093\/eurheartj\/ehae176","article-title":"2024 ESC Guidelines for the management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS)","volume":"45","author":"Van Gelder","year":"2024","journal-title":"Eur Heart J"},{"key":"10.1016\/j.hrthm.2025.07.034_bib6","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1055\/s-0044-1786028","article-title":"Clinical outcomes of patients with atrial fibrillation who survived from bleeding event: the results from COOL-AF Thailand registry","volume":"124","author":"Winijkul","year":"2024","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.hrthm.2025.07.034_bib7","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.pcad.2015.07.003","article-title":"Oral anticoagulant therapy in atrial fibrillation patients at high stroke and bleeding risk","volume":"58","author":"Potpara","year":"2015","journal-title":"Prog Cardiovasc Dis"},{"key":"10.1016\/j.hrthm.2025.07.034_bib8","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1055\/a-1515-9630","article-title":"Adherence to the \u2018Atrial Fibrillation Better Care\u2019 pathway in patients with atrial fibrillation: impact on clinical outcomes-a systematic review and meta-analysis of 285,000 patients","volume":"122","author":"Romiti","year":"2022","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.hrthm.2025.07.034_bib9","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.thromres.2023.08.016","article-title":"Thromboembolic and bleeding complications during interruptions and after discontinuation of anticoagulant treatment in patients with atrial fibrillation and active cancer: a daily practice evaluation","volume":"230","author":"Chu","year":"2023","journal-title":"Thromb Res"},{"key":"10.1016\/j.hrthm.2025.07.034_bib10","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.117.005657","article-title":"Thromboembolic risk, bleeding outcomes and effect of different antithrombotic strategies in very elderly patients with atrial fibrillation: a sub-analysis from the PREFER in AF (PREvention oF Thromboembolic Events-European Registry in Atrial Fibrillation)","volume":"6","author":"Patti","year":"2017","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.hrthm.2025.07.034_bib11","doi-asserted-by":"crossref","DOI":"10.1093\/europace\/euae021","article-title":"Impact of chronic obstructive pulmonary disease in patients with atrial fibrillation: an analysis from the GLORIA-AF registry","volume":"26","author":"Romiti","year":"2023","journal-title":"Europace"},{"key":"10.1016\/j.hrthm.2025.07.034_bib12","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2022.101652","article-title":"Frailty prevalence and impact on outcomes in patients with atrial fibrillation: a systematic review and meta-analysis of 1,187,000 patients","volume":"79","author":"Proietti","year":"2022","journal-title":"Ageing Res Rev"},{"key":"10.1016\/j.hrthm.2025.07.034_bib13","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1055\/s-0043-1770724","article-title":"Effect of oral anticoagulants in atrial fibrillation patients with polypharmacy: a meta-analysis","volume":"125","author":"Zheng","year":"2025","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.hrthm.2025.07.034_bib14","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1055\/s-0043-1769735","article-title":"The impact of polypharmacy on the effectiveness and safety of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation","volume":"124","author":"Grymonprez","year":"2024","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.hrthm.2025.07.034_bib15","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2024.102974","article-title":"Adverse events in clinically complex elderly patients with atrial fibrillation according to oral anticoagulation status","volume":"78","author":"Bucci","year":"2024","journal-title":"EClinicalMedicine"},{"key":"10.1016\/j.hrthm.2025.07.034_bib16","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1093\/ageing\/afab024","article-title":"Reasons for discontinuing oral anticoagulation therapy for atrial fibrillation: a systematic review","volume":"50","author":"Buck","year":"2021","journal-title":"Age Ageing"},{"key":"10.1016\/j.hrthm.2025.07.034_bib17","doi-asserted-by":"crossref","first-page":"7712","DOI":"10.3390\/jcm12247712","article-title":"Discontinuation of oral anticoagulants in atrial fibrillation patients: impact of treatment strategy and on patients\u2019 health status","volume":"12","author":"Nakamaru","year":"2023","journal-title":"J Clin Med"},{"key":"10.1016\/j.hrthm.2025.07.034_bib18","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.121.023907","article-title":"Global oral anticoagulation use varies by region in patients with recent diagnosis of atrial fibrillation: the GLORIA-AF Phase III registry","volume":"11","author":"Bayer","year":"2022","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.hrthm.2025.07.034_bib19","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1007\/s00392-021-01957-1","article-title":"Dabigatran versus vitamin K antagonists for atrial fibrillation in clinical practice: final outcomes from Phase III of the GLORIA-AF registry","volume":"111","author":"Huisman","year":"2022","journal-title":"Clin Res Cardiol"},{"key":"10.1016\/j.hrthm.2025.07.034_bib20","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1055\/a-2269-1123","article-title":"Racial differences in bleeding risk: an ecological epidemiological study comparing Korea and United Kingdom subjects","volume":"124","author":"Kang","year":"2024","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.hrthm.2025.07.034_bib21","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1055\/a-2278-8769","article-title":"Racial differences in ischemic and hemorrhagic stroke: an ecological epidemiological study","volume":"124","author":"Kang","year":"2024","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.hrthm.2025.07.034_bib22","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1007\/s00392-022-01996-2","article-title":"Comparative effectiveness and safety of non-vitamin K antagonists for atrial fibrillation in clinical practice: GLORIA-AF Registry","volume":"111","author":"Lip","year":"2022","journal-title":"Clin Res Cardiol"},{"key":"10.1016\/j.hrthm.2025.07.034_bib23","doi-asserted-by":"crossref","first-page":"2030","DOI":"10.1055\/s-0042-1756355","article-title":"Clinical complexity domains, anticoagulation, and outcomes in patients with atrial fibrillation: a report from the GLORIA-AF registry Phase II and III","volume":"122","author":"Romiti","year":"2022","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.hrthm.2025.07.034_bib24","doi-asserted-by":"crossref","DOI":"10.1093\/ageing\/afaf139","article-title":"Long-term clinical outcomes of oral anticoagulation in the older patients with atrial fibrillation aged \u226580 years: a report from the GLORIA-AF registry phase III","volume":"54","author":"Liu","year":"2025","journal-title":"Age Ageing"},{"key":"10.1016\/j.hrthm.2025.07.034_bib25","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.amjcard.2019.10.047","article-title":"Dabigatran persistence and outcomes following discontinuation in atrial fibrillation patients from the GLORIA-AF registry","volume":"125","author":"Paquette","year":"2020","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.hrthm.2025.07.034_bib26","article-title":"Therapeutic strategies following major, clinically relevant nonmajor, and nuisance bleeding in atrial fibrillation: findings from ORBIT-AF","volume":"7","author":"O\u2019Brien","year":"2018","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.hrthm.2025.07.034_bib27","doi-asserted-by":"crossref","first-page":"2322","DOI":"10.1111\/jth.15415","article-title":"Risks associated with discontinuation of oral anticoagulation in newly diagnosed patients with atrial fibrillation: results from the GARFIELD-AF Registry","volume":"19","author":"Cools","year":"2021","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.hrthm.2025.07.034_bib28","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1002\/jcsm.13499","article-title":"Physical frailty, genetic predisposition, and incident arrhythmias","volume":"15","author":"Zhang","year":"2024","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"10.1016\/j.hrthm.2025.07.034_bib29","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1186\/s12916-024-03373-4","article-title":"Patterns of comorbidities in patients with atrial fibrillation and impact on management and long-term prognosis: an analysis from the Prospective Global GLORIA-AF Registry","volume":"22","author":"Romiti","year":"2024","journal-title":"BMC Med"},{"key":"10.1016\/j.hrthm.2025.07.034_bib30","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/s12916-025-03858-w","article-title":"Patterns of pharmacological treatment in patients with atrial fibrillation: an analysis from the prospective GLORIA-AF Registry Phase III","volume":"23","author":"Corica","year":"2025","journal-title":"BMC Med"},{"key":"10.1016\/j.hrthm.2025.07.034_bib31","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1001\/jama.2017.13883","article-title":"Association between use of non-vitamin K Oral anticoagulants with and without concurrent medications and risk of major bleeding in nonvalvular atrial fibrillation","volume":"318","author":"Chang","year":"2017","journal-title":"JAMA"},{"key":"10.1016\/j.hrthm.2025.07.034_bib32","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.7326\/M20-7141","article-title":"Frailty and clinical outcomes of direct oral anticoagulants versus warfarin in older adults with atrial fibrillation : a cohort study","volume":"174","author":"Kim","year":"2021","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.hrthm.2025.07.034_bib33","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1186\/s12916-020-01870-w","article-title":"Clinical outcomes in patients with atrial fibrillation and frailty: insights from the ENGAGE AF-TIMI 48 trial","volume":"18","author":"Wilkinson","year":"2020","journal-title":"BMC Med"},{"key":"10.1016\/j.hrthm.2025.07.034_bib34","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.ejim.2022.11.004","article-title":"Impact of ABC (Atrial Fibrillation Better Care) pathway adherence in high-risk subgroups with atrial fibrillation: a report from the ESC-EHRA EORP-AF long-term general registry","volume":"107","author":"Ding","year":"2023","journal-title":"Eur J Intern Med"},{"key":"10.1016\/j.hrthm.2025.07.034_bib35","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2023.102039","article-title":"Patterns of oral anticoagulant use and outcomes in Asian patients with atrial fibrillation: a post-hoc analysis from the GLORIA-AF Registry","volume":"63","author":"Romiti","year":"2023","journal-title":"EClinicalMedicine"},{"key":"10.1016\/j.hrthm.2025.07.034_bib36","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1038\/nrcardio.2014.118","article-title":"Global epidemiology of atrial fibrillation","volume":"11","author":"Rahman","year":"2014","journal-title":"Nat Rev Cardiol"},{"key":"10.1016\/j.hrthm.2025.07.034_bib37","doi-asserted-by":"crossref","first-page":"2376","DOI":"10.1160\/TH17-08-0555","article-title":"Regional differences in antithrombotic treatment for atrial fibrillation: insights from the GLORIA-AF Phase II registry","volume":"117","author":"Mazurek","year":"2017","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.hrthm.2025.07.034_bib38","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.ejim.2020.04.032","article-title":"Influence of BMI and geographical region on prescription of oral anticoagulants in newly diagnosed atrial fibrillation: the GLORIA-AF Registry Program","volume":"80","author":"Boriani","year":"2020","journal-title":"Eur J Intern Med"},{"key":"10.1016\/j.hrthm.2025.07.034_bib39","doi-asserted-by":"crossref","first-page":"4899","DOI":"10.1093\/eurheartj\/ehac587","article-title":"Bleeding and ischaemic events after first bleed in anticoagulated atrial fibrillation patients: risk and timing","volume":"43","author":"Meyre","year":"2022","journal-title":"Eur Heart J"},{"key":"10.1016\/j.hrthm.2025.07.034_bib40","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1136\/heartjnl-2020-317229","article-title":"Premature permanent discontinuation of apixaban or warfarin in patients with atrial fibrillation","volume":"107","author":"Carnicelli","year":"2021","journal-title":"Heart"},{"key":"10.1016\/j.hrthm.2025.07.034_bib41","doi-asserted-by":"crossref","DOI":"10.1016\/j.exger.2021.111482","article-title":"Relationship between multimorbidity and outcomes in atrial fibrillation","volume":"153","author":"Proietti","year":"2021","journal-title":"Exp Gerontol"},{"key":"10.1016\/j.hrthm.2025.07.034_bib42","doi-asserted-by":"crossref","DOI":"10.1016\/j.jnha.2024.100430","article-title":"Poor clinical outcomes associated to multimorbidity, frailty and malnutrition in patients with atrial fibrillation","volume":"29","author":"Soler-Espejo","year":"2025","journal-title":"J Nutr Health Aging"},{"key":"10.1016\/j.hrthm.2025.07.034_bib43","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1136\/heartjnl-2020-317887","article-title":"Discontinuation of oral anticoagulation in atrial fibrillation and risk of ischaemic stroke","volume":"107","author":"Garc\u00eda Rodr\u00edguez","year":"2020","journal-title":"Heart"},{"key":"10.1016\/j.hrthm.2025.07.034_bib44","doi-asserted-by":"crossref","first-page":"2021","DOI":"10.1185\/03007995.2015.1082995","article-title":"Stroke associated with discontinuation of warfarin therapy for atrial fibrillation","volume":"31","author":"Spivey","year":"2015","journal-title":"Curr Med Res Opin"},{"key":"10.1016\/j.hrthm.2025.07.034_bib45","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1159\/000446406","article-title":"Risk of ischemic stroke in high risk atrial fibrillation patients during periods of warfarin discontinuation for surgical procedures","volume":"42","author":"Qureshi","year":"2016","journal-title":"Cerebrovasc Dis"},{"key":"10.1016\/j.hrthm.2025.07.034_bib46","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.119.014376","article-title":"Ischemic stroke and transient ischemic attack risk following vitamin K antagonist cessation in newly diagnosed atrial fibrillation: a cohort study","volume":"9","author":"Martinez","year":"2020","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.hrthm.2025.07.034_bib47","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.ahj.2020.04.016","article-title":"Discontinuation rates of warfarin versus direct acting oral anticoagulants in US clinical practice: results from Outcomes Registry for Better Informed Treatment of Atrial Fibrillation II (ORBIT-AF II)","volume":"226","author":"Jackson","year":"2020","journal-title":"Am Heart J"},{"key":"10.1016\/j.hrthm.2025.07.034_bib48","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1038\/nrcardio.2017.153","article-title":"The ABC pathway: an integrated approach to improve AF management","volume":"14","author":"Lip","year":"2017","journal-title":"Nat Rev Cardiol"},{"key":"10.1016\/j.hrthm.2025.07.034_bib49","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1038\/s41591-025-03511-2","article-title":"Telemedicine-based integrated management of atrial fibrillation in village clinics: a cluster randomized trial","volume":"31","author":"Chu","year":"2025","journal-title":"Nat Med"},{"key":"10.1016\/j.hrthm.2025.07.034_bib50","first-page":"279","article-title":"Safety of switching from a vitamin K antagonist to a non-vitamin K antagonist oral anticoagulant in frail older patients with atrial fibrillation: results of the FRAIL-AF randomized controlled trial","volume":"149","author":"Joosten","year":"2024","journal-title":"Circulation"},{"key":"10.1016\/j.hrthm.2025.07.034_bib51","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1160\/TH15-04-0350","article-title":"Therapy persistence in newly diagnosed non-valvular atrial fibrillation treated with warfarin or NOAC. A cohort study","volume":"115","author":"Martinez","year":"2016","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.hrthm.2025.07.034_bib52","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1016\/j.hrthm.2024.01.025","article-title":"Comparison of different direct oral anticoagulant regimens in atrial fibrillation patients with high bleeding risk","volume":"21","author":"Ciou","year":"2024","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.hrthm.2025.07.034_bib53","doi-asserted-by":"crossref","first-page":"f81","DOI":"10.1093\/ehjcvp\/pvaa020","article-title":"The importance of adherence and persistence with oral anticoagulation treatment in patients with atrial fibrillation","volume":"7","author":"Vitolo","year":"2021","journal-title":"Eur Heart J Cardiovasc Pharmacother"},{"key":"10.1016\/j.hrthm.2025.07.034_bib54","doi-asserted-by":"crossref","first-page":"4126","DOI":"10.1093\/eurheartj\/ehab421","article-title":"Predictors, time course, and outcomes of persistence patterns in oral anticoagulation for non-valvular atrial fibrillation: a Dutch Nationwide Cohort Study","volume":"42","author":"Toorop","year":"2021","journal-title":"Eur Heart J"},{"key":"10.1016\/j.hrthm.2025.07.034_bib55","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1136\/heartjnl-2016-310672","article-title":"Early non-persistence with dabigatran and rivaroxaban in patients with atrial fibrillation","volume":"103","author":"Jackevicius","year":"2017","journal-title":"Heart"},{"key":"10.1016\/j.hrthm.2025.07.034_bib56","doi-asserted-by":"crossref","first-page":"1722","DOI":"10.1093\/europace\/euab091","article-title":"Persistence and adherence to non-vitamin K antagonist oral anticoagulant treatment in patients with atrial fibrillation across five Western European countries","volume":"23","author":"Komen","year":"2021","journal-title":"Europace"},{"key":"10.1016\/j.hrthm.2025.07.034_bib57","doi-asserted-by":"crossref","first-page":"2263","DOI":"10.1016\/j.jacc.2012.04.063","article-title":"Inflammation in atrial fibrillation","volume":"60","author":"Guo","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.hrthm.2025.07.034_bib58","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.122.028482","article-title":"Relationship between endothelial dysfunction and the outcomes after atrial fibrillation ablation","volume":"12","author":"Okawa","year":"2023","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.hrthm.2025.07.034_bib59","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1016\/S0140-6736(19)31786-6","article-title":"Frailty: implications for clinical practice and public health","volume":"394","author":"Hoogendijk","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.hrthm.2025.07.034_bib60","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2022.101666","article-title":"The prevalence of frailty and pre-frailty among geriatric hospital inpatients and its association with economic prosperity and healthcare expenditure: a systematic review and meta-analysis of 467,779 geriatric hospital inpatients","volume":"80","author":"Doody","year":"2022","journal-title":"Ageing Res Rev"},{"key":"10.1016\/j.hrthm.2025.07.034_bib61","article-title":"Association of comorbidity patterns with outcomes and relation with the ABC pathway effectiveness in European patients with atrial fibrillation","author":"Romiti","year":"2025","journal-title":"Heart Rhythm Forthcoming"},{"key":"10.1016\/j.hrthm.2025.07.034_bib62","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1055\/s-0043-1769612","article-title":"Mobile health-technology-integrated care for atrial fibrillation: a win ratio analysis from the mAFA-II randomized clinical trial","volume":"123","author":"Romiti","year":"2023","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.hrthm.2025.07.034_bib63","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1055\/s-0043-1772773","article-title":"Non-vitamin K antagonist oral anticoagulant, warfarin, and ABC pathway adherence on hierarchical outcomes: win ratio analysis of the COOL-AF registry","volume":"124","author":"Treewaree","year":"2024","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.hrthm.2025.07.034_bib64","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1001\/jamaneurol.2024.2882","article-title":"Left atrial appendage occlusion vs standard of care after ischemic stroke despite anticoagulation","volume":"81","author":"Maarse","year":"2024","journal-title":"JAMA Neurol"},{"key":"10.1016\/j.hrthm.2025.07.034_bib65","article-title":"An international consensus practical guide on left atrial appendage closure for the non-implanting physician: executive summary","author":"Potpara","year":"2024","journal-title":"Thromb Haemost Forthcoming"},{"key":"10.1016\/j.hrthm.2025.07.034_bib66","doi-asserted-by":"crossref","first-page":"e277","DOI":"10.1016\/j.hrthm.2025.02.013","article-title":"Racial differences and similarities in atrial fibrillation epidemiology and risk factors in UK Biobank and Korean NHIS-HEALS cohort studies","volume":"22","author":"Kim","year":"2025","journal-title":"Heart Rhythm"}],"container-title":["Heart Rhythm"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1547527125027158?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1547527125027158?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T07:25:37Z","timestamp":1780557937000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1547527125027158"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":66,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["S1547527125027158"],"URL":"https:\/\/doi.org\/10.1016\/j.hrthm.2025.07.034","relation":{},"ISSN":["1547-5271"],"issn-type":[{"value":"1547-5271","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinical phenotype of anticoagulant discontinuation and the long-term prognosis in atrial fibrillation patients with high bleeding risk: A report from the GLORIA-AF registry","name":"articletitle","label":"Article Title"},{"value":"Heart Rhythm","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.hrthm.2025.07.034","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Heart Rhythm Society.","name":"copyright","label":"Copyright"}]}}